Simplex Trading’s Akcea Therapeutics Inc AKCA Stock Holding History

Simplex Trading’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-400	Closed	-$7K	–	9493
2020 Q3	$7K	Buy	400 +359	+876%	+$5.09K	﹤0.01%	6996
2020 Q2	$0	Buy	+41	New	+$633	﹤0.01%	8753
2019 Q4	–	Sell	-100	Closed	-$1.86K	–	8323
2019 Q3	$1K	Sell	100 -1,017	-91%	-$21.7K	﹤0.01%	7127
2019 Q2	$26K	Sell	1,117 -194	-15%	-$4.79K	﹤0.01%	5415
2019 Q1	$37K	Buy	+1,311	New	+$38.2K	﹤0.01%	5253

Simplex Trading's AKCA Position: Q4 2020 in Review

Simplex Trading sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 400 shares — an estimated $7K sold.

Simplex Trading first reported a position in AKCA in Q1 2019 and held it in 5 quarters. The position peaked at $37K in Q1 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Simplex Trading reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Simplex Trading sold 400 Akcea Therapeutics Inc shares in Q4 2020, an estimated $7K.
Simplex Trading first reported a position in Akcea Therapeutics Inc in Q1 2019 and held it in 5 quarters.
Simplex Trading's Akcea Therapeutics Inc position peaked at $37K in Q1 2019.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Simplex Trading's 13F filing for Q4 2020, filed 2 Feb 2021.